TB services: latest news

TB services features

TB services news from aidsmap

More news

TB services news selected from other sources

  • Mass TB Tests 'Would Save Billions'

    A World Bank study has estimated that South Africa, Lesotho, Swaziland, and Mozambique could save approximately 13 billion rand a year in increased productivity and reduced TB transmission by spending 330 million rand per year to test and treat miners in the gold and platinum mining industry for TB.

    31 March 2014 | Business Daily
  • Xpert TB test doesn’t reduce morbidity but it does have important advantages

    While it is disappointing that the Xpert did not confer a morbidity or mortality benefit, its advantages include quicker and easier diagnosis with less work for health workers.

    10 March 2014 | HIV i-Base
  • TB treatment must extend beyond the physical body and include social and psychological support as an important aspect of care

    Jigna Rao, patient advocate, speaks about patient centered approaches to cure at the TAG symposium “Cascades: Improving TB Care”, held on November 1 during the 2013 Union World Conference on Lung Health in Paris, France.

    18 November 2013 | TB Online
  • Global Fund Shift Mode of Funding, to Focus on Joint HIV/TB Programs

    The Global Fund has said future funding programmes will be geared towards joint Tuberculosis and HIV programmes, rather than separate proposals for each disease. The new requirement is designed to streamline programming for countries heavily burdened by the two diseases.

    08 November 2013 | Africa Science News
  • Patient-Centered TB Treatment Will Require Modernizing Directly-Observed Therapy

    In the first of two linked posts, Mike Frick of Treatment Action Group (TAG) and Audrey Zhang of Harvard College argue that patient-centered approaches in treatment for drug-resistant and drug-sensitive tuberculosis are needed.

    31 October 2013 | PLoS Blogs (blog)
  • Pros and cons of high-tech TB testing

    A new, sophisticated diagnostic test for tuberculosis now being rolled out promises to be faster and more accurate than the old methods and much easier to use. But the first trials of the GeneXpert MTB/RIF Assay test in real-life situations have proved that while all this is true, it did not make any significant difference to treatment outcomes.

    30 October 2013 | IRIN
  • Mapping the Donor Landscape in Global Health: Tuberculosis

    This report maps the network of international assistance aimed at addressing the global impact of tuberculosis (TB). The analysis identifies 22 different donors, comprising 19 nations providing bi-lateral support and 3 multilateral programs, providing assistance to 109 recipient countries over a three-year period through 2011.

    02 September 2013 | Kaiser Family Foundation
  • Kenyan government now sets the pace in war against tuberculosis

    Prevalence of TB cases in Kenya has prompted the government and donors to turn to social model in a bid to win the war against the deadly diseases. The model ensures that TB patients get the best social support available, which removes stigma that sent patients to an early grave.

    29 July 2013 | The East African
  • Directly Observed Therapy for Tuberculosis No Better than Self-Administration

    People who self-administered drugs to treat tuberculosis (TB) and those receiving directly observed therapy (DOT) had similar outcomes, according to a meta-analysis of 10 studies described in the July 2013 issue of Clinical Infectious Diseases.

    14 June 2013 | HIVandHepatitis.com
  • US: TB programs affected by isoniazid shortage

    A shortage of isoniazid interfered with patient care and may contribute to the spread of tuberculosis in the United States, according to a report by the CDC. “Interruptions in the supply of second-line anti-TB medications have been ongoing in the United States for several years,” the researchers wrote in Morbidity and Mortality Weekly Report. “But since November 2012, TB control programs have experienced the first sustained generalized supply interruption of a first-line anti-TB medication.”

    24 May 2013 | Healio
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.